Related Experiment Videos

[Dopamin-beta-hydroxylaseaktivität im Plasma von Dialysepatienten (author's transl)]

Klinische Wochenschrift
|November 15, 1977
PubMed

Insights

Plasma dopamine-beta-hydroxylase (DBH) is lower in hemodialysis patients, indicating reduced sympathetic activity. However, DBH levels increase during ultrafiltration, showing an appropriate sympathetic response to volume loss.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Nephrology

Context:

  • Dopamine-beta-hydroxylase (DBH) is a key enzyme in catecholamine synthesis.
  • Hemodialysis patients often exhibit altered sympathetic nervous system activity.
  • Understanding DBH in this population is crucial for managing cardiovascular complications.

Purpose:

  • To investigate plasma DBH levels in hemodialysis patients compared to healthy controls.
  • To assess the relationship between DBH activity and sympathetic function during hemodialysis.
  • To explore the dynamic changes in DBH during the ultrafiltration process.

Summary:

  • Plasma DBH levels were significantly lower in 37 hemodialysis patients (32.5 +/- 17.6 IU) compared to 70 healthy controls (50.0 +/- 29.3 IU).
  • No significant differences in basal DBH were observed between males and females, nor was there a correlation with age in controls.
  • Plasma DBH activity increased during ultrafiltration in hemodialysis patients, suggesting a sympathetic reflex response to volume depletion.

Impact:

  • Findings suggest potentially lowered sympathetic activity in hemodialysis patients.
  • The observed rise in DBH during ultrafiltration indicates a preserved sympathetic reflex mechanism.
  • This research contributes to understanding neuro-autonomic dysfunction in chronic kidney disease.

Related Concept Videos